Assessing the Reliability of Hysteroscopic Sampling Methods for Diagnosing Atypical Endometrial Hyperplasia
Authors:
- Luca GiannellaLGLuca Giannella
- Francesco PivaFPFrancesco Piva
- Giovanni Delli CarpiniGiovanni Delli Carpini
- Jacopo Di GiuseppeJGJacopo Di Giuseppe
- Matteo GiuliettiMatteo Giulietti
- Erica DugoEDErica Dugo
- Francesco SopracordevoleFSFrancesco Sopracordevole
- Anna Del FabroAFAnna Del Fabro
- Nicolò ClementeNCNicolò Clemente
- Barbara GardellaBGBarbara Gardella
- Giorgio BoganiGBGiorgio Bogani
- Orsola BrasileOBOrsola Brasile
Open Access
Abstract
Background/Objectives: The diagnosis of atypical endometrial hyperplasia (AEH) is associated with a high rate of concurrent endometrial cancer (EC). This occurrence can be particularly challenging in premenopausal women wishing to become pregnant, as they may be subjected to conservative treatment. The type of endometrial sampling may affect this outcome. Currently, the recommended type of endometrial sampling is under hysteroscopic guidance. There is scant literature regarding the reliability of hysteroscopically guided biopsy (HSC-bio) and hysteroscopic endometrial resection (HSC-res) on this topic. We aimed to assess the underestimation rate of EC in AEH, according to different hysteroscopic sampling methods. The secondary outcome was to evaluate the procedure performance in pre- and postmenopausal women. Methods: We conducted a multi-institutional retrospective study that included 536 women diagnosed with AEH who underwent hysterectomy between 2015 and 2020. Patients were divided into two groups based on the initial diagnostic approach for AEH: HSC-bio and HSC-res. The comparison was performed using univariate and multivariate analyses. Results: 160/536 women (29.9%) showed EC at hysterectomy. Overall, the following rate of EC underestimation was found: HSC-bio = 32.1%, HSC-res = 24.2%, p = 0.07. After adjusting for baseline characteristics using logistic regression analysis, overall, there was no significant association of EC underestimation according to the type of sampling procedure. Interestingly, in premenopausal women, including 161 cases, the rate of EC underestimation in HSC-bio and HSC-res was 28.8% vs. 14.0%, respectively (p = 0.034). Conclusions: There were no significant differences in EC underestimation between the two hysteroscopic procedures in the entire cohort of women with AEH. Limited to the secondary objective, the significant findings in premenopausal women may be of particular clinical interest, as this population may undergo conservative treatment.Keywords
This publication has 32 references indexed in Scilit:
- Is there a role for the sentinel lymph node in endometrial atypical hyperplasia? Insights from an ESGO-accredited InstitutionEuropean Journal of Surgical Oncology, 2025
- Endometrial hyperplasia as a risk factor of endometrial cancerArchives of Gynecology and Obstetrics, 2022
- Hysteroscopic resectoscope-directed biopsies and outpatient endometrial sampling for assessment of tumor histology in women with endometrial cancer or atypical hyperplasiaEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2020
- Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: Safety and EfficacyJournal of Minimally Invasive Gynecology, 2015
- New mini-resectoscope: analysis of preliminary quality results in outpatient hysteroscopic polypectomyArchives of Gynecology and Obstetrics, 2013
- Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysisAmerican Journal of Obstetrics and Gynecology, 2012
- Lymph node dissection in the surgical management of atypical endometrial hyperplasiaAmerican Journal of Obstetrics and Gynecology, 2010
- Validation of hysteroscopic view in cases of endometrial hyperplasia and cancer in patients with abnormal uterine bleedingJournal of Minimally Invasive Gynecology, 2006
- The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasiaCancer, 2000
- Concomitant Endometrial Hyperplasia in Patients with Endometrial CarcinomaGynecologic Oncology, 1998